3B BlackBio Dx Limited develops, manufactures, and commercializes PCR-based molecular diagnostic kits, PCR enzymes, and PCR reagents. Its products address areas including infectious diseases, oncology, human genetics, antimicrobial resistance, and nucleic-acid extraction. The company markets its molecular diagnostic products under the TRUPCR brand and also operates in rapid diagnostics and next-generation sequencing assays. Growing adoption of molecular testing and demand for faster diagnostic solutions support the company's addressable market. Research, product development, and expansion of diagnostic applications remain important growth drivers.
| Market cap | Sales (TTM) | Net profit (TTM) | P/E | EPS (TTM) | P/B | ROE | Beta |
|---|---|---|---|---|---|---|---|
| ₹1,143 cr | — | — | 21.9 | 66.16 | 3.43 | 17.0% | — |
| Method | Checks | Score | Verdict |
|---|---|---|---|
| Turtle | ✗ Close above the prior 55-session high · 1,740.00 ✗ Close above the prior 20-session high · 1,740.00 ✗ Close below the prior 20-session low · 1,289.80 Donchian channel breakout - the Turtle traders' entry. | No signal | |
| Graham | ✗ Price at or below the Graham number · Graham number 760.09 ✗ P/E 15 or less · P/E 20.1 ✗ P/B 1.5 or less (or P/E x P/B 22.5 or less) · P/B 3.43 — Current ratio 2 or more — 10 years of positive earnings, 20 of dividends · history not held Benjamin Graham's defensive-investor tests. | 57/100 | Expensive |
| Stock | 1M % | 3M % | 6M % | 1Y % | 3Y % | 5Y % | P/E | P/B | ROE % | ROCE % | ROA % | D/E | EV/EBITDA | ₹ Cr | Sales TTM ₹ Cr | Profit TTM ₹ Cr | EPS | Beta |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3BBLACKBIO this stock | +0.9 | +5.0 | +2.2 | — | — | — | 21.9 | 3.43 | 17.0 | — | — | — | — | 1,143 | — | — | 66.2 | — |
| NOVARTIND | -6.1 | +15.2 | +93.0 | +185.8 | +169.7 | +140.4 | 47.5 | 5.80 | 12.0 | — | — | — | — | 4,745 | — | — | 39.6 | — |
| PREMIERPOL | +30.2 | +43.3 | +103.1 | +140.8 | +275.1 | +641.0 | 30.1 | 6.69 | 24.1 | 32.9 | — | 0.00 | 24.3 | 1,123 | 396 | 37 | 3.5 | 0.61 |
| CALSOFT | -18.4 | +38.8 | +158.0 | +79.1 | +128.5 | -13.1 | 13.5 | 4.79 | 32.3 | 42.0 | — | 0.04 | — | — | 25 | 15 | 2.4 | 0.57 |
| VALIANTLAB | +14.2 | +119.9 | +111.8 | +70.1 | -27.6 | — | 47.7 | 2.46 | -1.2 | 0.8 | — | 0.14 | 88.7 | 764 | 306 | 16 | 3.0 | 0.81 |
| KENNAMET | -3.8 | +48.0 | +67.3 | +66.3 | +56.4 | +189.5 | 46.2 | 10.60 | 23.0 | — | — | — | — | 9,052 | — | — | 89.2 | — |
| AKSHARCHEM | +5.8 | +76.5 | +98.6 | +57.4 | +48.9 | -20.8 | 23.7 | 1.27 | -0.2 | 0.7 | — | 0.41 | 23.5 | 333 | 416 | 14 | 17.5 | 0.81 |
| CHEMBONDCH | -17.5 | -11.4 | +49.0 | +48.5 | — | — | 15.9 | 2.92 | 18.5 | — | — | 0.00 | 12.1 | 605 | 347 | 38 | 14.2 | 1.28 |
| IVP | -2.1 | +33.7 | +47.2 | +34.0 | +23.5 | +77.2 | 6.9 | 1.38 | 12.6 | 13.9 | — | 0.42 | 7.5 | 217 | 611 | 32 | 30.5 | 1.05 |
| MARALOVER | -2.2 | +5.6 | +29.1 | +29.1 | -15.4 | -28.2 | — | 2.17 | — | — | — | — | — | — | — | — | — | 1.03 |
| NAHARSPING | -7.2 | -11.0 | -1.6 | +25.4 | -11.3 | -47.6 | 11.4 | 0.60 | 1.5 | 3.2 | — | 0.65 | 11.0 | 901 | 3,365 | 76 | 21.9 | 1.22 |